E-Bayesian Point Estimation and Comparative

0 downloads 0 Views 713KB Size Report
10 Microlife BP3AG1 141501***. 23.12.2015. 23.12.2015. 09.12.2015 test operating instructions, testing – without deviation. 11 Microlife BP3AG1 141500***.
E-Bayesian Point Estimation and Comparative Analysis of the Operational Reliability Related to Electronic Items for Medical Purpose Julia Garipova, Anton Georgiev, and Toncho Papanchev Department of Electronics Technical University of Varna Varna, Bulgaria [email protected] Abstract—This paper is focused on the medical items reliability analysis and comparison of the evaluated reliability indices per three types of measuring items containing electronic and mechanical modules. The analysis is based on the study of exponential model parameters by means of reliability parametric E-Bayesian estimation. The point estimation values of operational reliability indices valid for the medical items under study are experimentally obtained. This paper is presented an extension of previous research concerning the E-Bayesian evaluation of medical equipment operational reliability. Keywords—E-Bayesian point estimates; operational reliability data analysis; type I censored data;

I. INTRODUCTION Reliability of medical electronic systems is an important factor in determining the correct diagnosis of patients and accurately analyzing the specific causes of the disease [1], [2], [3], [4]. The approaches discussed below are of general scope and can be used for medical items reliability evaluation and for evaluation in many other cases as well [5]. The reliability analyzes performed in this paper are based on the assumption that the thermal regimes of medical electronic systems are provided [6]. The basis of this research is real statistical data regarding operational events that occurred during the system operation. The case study is aimed at formalization of both the prior data and accumulated new sampling data related to different types of blood pressure monitors, for the purpose of reliability analysis.

are still functioning. The incomplete data (i.e. during the test not all the items are failed and so their failure times are unknown) is called censored. In this case, the data is right (type I) censored [7]. Therefore, the failure times ti are known and hence, there are defined the times for the survived items ti=t0. Thus, through the total likelihood L(λ), MLE Λ for λ is calculated as shown below nf

L    

nf

  t i

e

i 1

e    t0



nf

i t i

.

(1)

B. Empirical Bayesian Estimation (E-Bayesian Estimation) Let t1, t2,…, tn is the sampling data discussed above. As Bayesian estimator, the Gamma distribution conjugate prior function of failure rate λ is modeled. Eqn.2 represents the resultant probability density function (pdf) [7], where E is a function of the hyper parameters (α, β), and α is the number of total failures occurred in βth time interval

  | E  

    1   e .   

(2)

According [7], the posterior Gamma distribution equation is obtained by applying the Bayes theorem. It is presented in Eqn.3, where α'=α+nf and β'=β+Σni=1 ti are the updated hyper parameters, and DN is the new accumulated empirical data

II. THE RELIABILITY APPROACH The approach developed includes the implementation of two estimation methods used to calculate the reliability indices estimation values – maximum likelihood estimation (MLE) and empirical Bayesian (E-Bayesian) estimation.

nw

  | D N , E  

      1    e .    

(3)

III. CASE STUDY A. Maximum Likelihood Estimation (MLE) Consider a set of n items that are under observation for up to time t0. A number nf of these items are failed with corresponding failure times t1, t2,…, tn. The other nw=n–nf items

978-1-5386-3419-6/18/$31.00 ©2018 IEEE

Several models of blood pressure monitors are studied – semi-automatic (SABPM) [8], automatic (APBM), and manual (MBPM). Service records are used, and information on operating intervals and failure times is fetched and classified as initial statistical data and latest (subsequent) statistical data.

Table 1 and Table 2 represent the information collected for ABPMs. The exponential distribution of the life (useful) time can be applied for these items. The collected information is presented as sampling data regarding operational events occurring during the operation. Therefore, for the purposes of E-Bayesian estimation, the data from both tables is presented as a prior and posterior data respectively.

TABLE I.

A. MLE of ABPMs Let the statistical data from Table 1 is presented as sampling data regarding operational events that occurredduring the operation of 27 ABPMs (n=27). As can be seen, 7 of all medical items are demonstrated a failure with corresponding failure times t1, t2,…, tnf (nf=13). Concerning the failed items, the failure times are evaluated from statistical data. Therefore, assuming that that the observed time period is

INITIAL STATISTICAL DATA REGARDING AUTOMATIC BLOOD PRESSURE MONITORS (ABPMS)

No

Product

Model

Serial number

Adoption date

Transmission date

Guarantee

Status

Comment

1

Microlife

BP 3AG1

241308***

24.06.2015

24.06.2015

12.06.2014

repair

***

replacement of arm cuff, testing – without deviation testing – without deviation testing – without deviation testing – without deviation testing – without deviation testing – without deviation testing – without deviation replacement of DC power jack, testing – without deviation testing – without deviation operating instructions, testing – without deviation testing – without deviation unfounded claims, testing – without deviation testing – without deviation repairing the AC adapter, testing – without deviation testing – without deviation adjusting of PRV, testing – without deviation testing – without deviation adjusting of PRV, testing – without deviation operating instructions, testing – without deviation testing – without deviation testing – without deviation testing – without deviation testing – without deviation cleaning of ADV, testing – without deviation transistor replacement, testing – without deviation testing – without deviation testing – without deviation

2 3 4 5 6 7

Microlife Microlife Microlife Microlife Microlife Microlife

BP 3AG1 BP 3AG1 BP 3AG1 BP 3AG1 BP 3AG1 BP 3AG1

001306 141208*** 141102*** 141208*** 261405*** 511204***

03.07.2015 06.07.2015 28.07.2015 28.07.2015 31.08.2015 30.11.2015

03.07.2015 06.07.2015 28.07.2015 28.07.2015 31.08.2015 30.11.2015

04.11.2014 18.12.2012 12.10.2012 04.08.2014 04.08.2015 17.04.2013

test test test test test test

8

Microlife

BP 3AG1

491301***

30.11.2015

30.11.2015

10.10.2015

repair

***

9

Microlife

BP 3AG1

241308

18.12.2015

18.12.2015

10.03.2014

test

10

Microlife

BP 3AG1

141501***

23.12.2015

23.12.2015

09.12.2015

test

11

Microlife

BP 3AG1

141500***

22.01.2016

22.01.2016

13.01.2016

test

12

Microlife

BP 3AG1

011407***

22.01.2016

22.01.2016

08.10.2014

test

13

Microlife

BP 3AG1

261403***

14.03.2016

14.03.2016

01.02.2016

test

14

Microlife

BP 3AG1

031301***

30.03.2016

30.03.2016

15.12.2015

repair

15

Microlife

BP 3AG1

261403***

26.04.2016

26.04.2016

13.01.2016

test

16

Microlife

BP 3AG1

011205***

27.05.2016

27.05.2016

05.05.2016

calibration

17

Microlife

BP 3AG1

281511***

20.06.2016

20.06.2016

16.04.2016

test

18

Microlife

BP 3AG1

031301***

20.06.2016

20.06.2016

30.12.2013

calibration

19

Microlife

BP 3AG1

261406***

25.08.2016

25.08.2016

04.09.2015

test

20 21 22 23

Microlife Microlife Microlife Microlife

BP 3AG1 BP 3AG1 BP 3AG1 BP 3AG1

261403*** 141208*** 361506*** 131402***

21.09.2016 21.09.2016 21.09.2016 15.12.2016

21.09.2016 21.09.2016 21.09.2016 15.12.2016

08.06.2015 04.08.2014 15.09.2016 28.06.2015

test test test test

24

Microlife

BP 3AG1

241307***

28.02.2017

28.02.2017

10.02.2014

prevention

***

25

Microlife

BP 3AG1

047900

28.02.2017

28.02.2017

15.07.2016

repair

26 27

Microlife Microlife

BP 3AG1 BP 3AG1

341407*** 481403***

19.05.2017 22.05.2017

19.05.2017 22.05.2017

10.04.2016 23.01.2017

test test

TABLE II.

LATEST STATISTICAL DATA ACCUMULATED REGARDING AUTOMATIC BLOOD PRESSURE MONITORS (ABPMS)

BP 3AG1

Serial number 481603***

Adoption date 08.06.2017

Transmission date 08.06.2017

BP 3AG1

191405***

27.06.2017

***

No

Product

Model

1

Microlife

2

Microlife

Guarantee

Status

Comment

25.05.2017

test

27.06.2017

12.01.2015

repair

testing – without deviation replacement of arm cuff, testing – without deviation testing – without deviation testing – without deviation testing – without deviation testing – without deviation testing – without deviation replacement of arm cuff, testing – without deviation replacement of AC/DC adapter, testing – without deviation testing – without deviation testing – without deviation repair of pump motor, testing – without deviation testing – without deviation testing – without deviation testing – without deviation

3 4 5 6 7

Microlife Microlife Microlife Microlife Microlife

BP 3AG1 BP 3AG1 BP 3AG1 BP 3AG1 BP 3AG1

191406 261403*** 479006*** 101400*** 481603***

27.06.2017 18.07.2017 15.08.2017 12.09.2017 21.09.2017

27.06.2017 18.07.2017 15.08.2017 12.09.2017 21.09.2017

12.03.2016 04.08.2015 15.07.2016 14.08.2014 25.08.2017

test test test test test

8

Microlife

BP 3AG1

491301***

28.09.2017

28.09.2017

12.11.2014

repair

***

9

Microlife

BP 3AG1

191406

23.10.2017

23.10.2017

24.05.2015

repair

10 11

Microlife Microlife

BP 3AG1 BP 3AG1

261405*** 191406***

02.11.2017 22.11.2017

02.11.2017

13.11.2015 06.06.2016

test test

12

Microlife

BP 3AG1

321602***

24.11.2017

24.11.2017

21.03.2017

repair

13 14 15

Microlife Microlife Microlife

BP 3AG1 BP 3AG1 BP 3AG1

521600*** 481601*** 321603***

12.12.2017 15.12.2017 02.02.2018

12.12.2017 15.12.2017 02.02.2018

25.10.2017 15.08.2017 30.08.2017

test test test

equal to the failure time (t0=ti) and by means of (1), the likelihood function can be found (Fig.1). λ, [hours-1]

0,00025

λabpm ABPM

0,0002

λmbpm MBPM

0,00015 0,0001

0,00005 0 0

5000

10000

15000

20000

25000

30000

t, [hours] Fig. 1. Failure Rate Estimation of ABPMs and MBPMs.

The MLE point estimation regarding ABPMs failure rate is evaluated by means of (1) as follows



nf

i t i

 8,9705.10 6 item/hour

B. E-Bayesian Estimation of ABPMs Consider sampling data accumulated regarding ABPMs life testing (Table 1). The conjuage prior on λ is modeled through (2). In relation to prior data from Table 1, the hyper parameter α is equaled to the total number of failures occurred from all the previous data, and the hyper parameter β is equaled to the total of all the failure hours in previous test, i.e. α=7 and β=58464. The expression of Gamma posterior pdf is given by (3) with updated hyper parameters α' and β'. From Table 2, the actual hyper parameter values are evaluated as α'=11 and β'=132360. The both of obtained conjugate prior and posterior pdf of the ABPMs under test are presented on Fig.2. 0.3

π(λ|E), π(λ|D N,E)

prior 0.25

posterior

0.2 0.15 0.1 0.05 0 0

0.000005

0.00001

0.000015

0.00002

0.000025

0.00003

0.000035

λ , [hours-1] Fig. 2. Prior and Posterior Gamma Distribution Function of ABPMs.

Consider initial sampling data accumulated regarding MBPMs (Table 3) and latest statistical data accumulated (Table 4). Applying the described approach, the reliability analysis of these type medical items is performed.

C. E-Bayesian Estimation of MBPMs Concerning this case, the conjuage prior on λ is also modeled by (2). In relation to prior data from Table 3, the hyper parameter values are α=17 and β=85032. From Table 4, the actual hyper parameters values are evaluated as α'=23 and β'=138216. The both of obtained conjugate prior and posterior pdf of the MBPMs under test are presented on Fig.3. 0.0016

prior

π(λ|E), π(λ|DN ,E)

0.0014

posterior

0.0012

estimates obtained through Bayesian application are expressed the items failure-resistance. This approach is appropriated to defining deadlines for prevention procedures as well as design electronic items with improved failure-resistance based on past experience. As opposed to other reliability methods such as classical structure reliability method, Markov chains, pattern recognition, etc., the E-Bayesian techniques are provided more flexible reliability analysis and ongoing update of reliability parameters values when the new data is accumulated. REFERENCES

0.001 0.0008

[1]

0.0006 0.0004 0.0002

0 0

0.00002

0.00004

0.00006

0.00008

0.0001

0.00012

λ , [hours-1]

Fig. 3. Prior and Posterior Gamma Distribution Function of MBPMs.

Fig.4 represents a comparison of the results obtained by applying MLE approach for SABPMs [8], ABPMs, and MBPMs. It is obvius that the MLE point estimation of MBPMs having the highest value due to the frequently observed failures demonstrated in the manometers and cameras of the medical items under test.

λ , [h-1]

0.00004

SABPMs 3.1244E-05

0.00003 0.00002

[2]

[3]

[4]

[5]

ABPMs MBPMs

1.53191E-05 8.97049E-06

0.00001

[6]

0

SABPMs

ABPMs

items under test

MBPMs

Fig. 4. Comparison of MLE failure rate values of the medical items under study.

IV. CONCLUSION This paper discusses two methods (MLE and E-Bayesian techniques) for operational reliability assessing of electronic items during their operational lifetime. The reliability

[7]

[8]

Ts. Georgiev, M. Ivanova, A. Kopchev, Ts, Velikova, A. Miloshov, E. Kurteva. Rheumatol Int (2018) 38: 821, “Cartilage oligomeric protein, matrix metalloproteinase-3, and Coll2-1 as serum biomarkers in knee osteoarthritis: a cross-sectional study,” Springer Berlin Heidelberg. Springer-Verlag GmbH Germany, part of Springer Nature 2017, Rheumatology International, pp 1-10, May 2018, Volume 38, Issue 5, pp 821–830, First Online: 21 November 2017. Ts. Georgiev, R. Dacheva, M. Ivanova, R. Stoilov and R. Rashkov, “The place of autologous platelet-rich plasma in the treatment of knee osteoarthritis: A systemic review,” Revmatologiia (Bulgaria) 24(4), 2016, pp. 3-13. Ts. Georgiev, R. Stoilov, M. Penkov, M. Ivanova and A. Trifonov, “Radiographic assessment of knee osteoarthritis”, Revmatologiia (Bulgaria) 24(2), 2016, pp. 16-24, Medical Information Center. Ts. Georgiev, R. Stoilov, and M. Ivanova, ”Biomarkers in osteoarthritis,” Revmatologiia (Bulgaria) 21(4), 2013, pp. 21-25, ISSN: 13100505, Medical Information Center. N. Nikolaev, S. Yordanov, R. Vasilev, “An optimization algorithm for simulating smart-grid means for distribution grid balacing,” Proc. Of the Second International Scientific Conference “Intelligent Information Technologies for Industry” (IITI’17). IITI 2017. Advances in Intelligent Systems and Computing, vol.679, Springer Cham pp 359-369, 2018. K. Yordanov, T. Mechkarova, A. Stoyanova and P. Zlateva, “Determination of the temperature of cathode unit of indirect plasma burner through a computer simulation model,” Proceedings of the Second International Scientific Conference “Intelligent Information Technologies for Industry” (IITI’17). IITI 2017. Advances in Intelligent Systems and Computing, vol. 680, Springer, Cham, pp. 403-409, 2018 A. O’Conner, M. Modarres, and A. Mosleh, “Probability Distribution Used in Reliability Engieering,” published by Center for Risk and Reliability. University of Martlang, College Park, 2011. J. Garipova, P. Georgieva, and A. Georgiev, “Empirical Bayesian estimates of operational reliability related to electronic items for medical Purpose,” Physics – Eternally Young Science, Kamchia, Bulgaria, 2018.

Suggest Documents